يعرض 81 - 90 نتائج من 1,506 نتيجة بحث عن '"Merola, Joseph"', وقت الاستعلام: 1.32s تنقيح النتائج
  1. 81
    دورية أكاديمية

    المساهمون: Oregon Health and Science University Portland (OHSU), The George Washington University (GW), NIHR Biomedical Research Centre London, Guy's and St Thomas' NHS Foundation Trust-King‘s College London, Lille Inflammation Research International Center - U 995 (LIRIC), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Università degli studi di Verona = University of Verona (UNIVR), University Medical Center Utrecht, University of Copenhagen = Københavns Universitet (UCPH), Ludwig Maximilian University Munich = Ludwig Maximilians Universität München (LMU)

    المصدر: ISSN: 1365-2133 ; The British journal of dermatology ; https://hal.univ-lille.fr/hal-04428303Test ; The British journal of dermatology, 2022, British Journal of Dermatology, 187, pp.888-899. ⟨10.1111/bjd.21867⟩.

    مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36082590; hal-04428303; https://hal.univ-lille.fr/hal-04428303Test; https://hal.univ-lille.fr/hal-04428303/documentTest; https://hal.univ-lille.fr/hal-04428303/file/bjd0888.pdfTest; PUBMED: 36082590

  2. 82
    دورية أكاديمية
  3. 83
    دورية أكاديمية
  4. 84
    دورية أكاديمية
  5. 85
    دورية أكاديمية

    وصف الملف: text

    العلاقة: https://eprints.gla.ac.uk/267411/1/267411.pdfTest; Ritchlin, C. T. et al. (2022) Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies. RMD Open , 8(1), e002195. (doi:10.1136/rmdopen-2022-002195 ) (PMID:35296534) (PMCID:PMC8928386)

  6. 86
    دورية أكاديمية

    وصف الملف: text

    العلاقة: https://eprints.gla.ac.uk/275808/1/275808.pdfTest; Coates, L. C. et al. (2022) Safety and efficacy of bimekizumab in patients with active psoriatic arthritis: 3-year results from a phase 2b randomized controlled trial and its open-label extension study. Arthritis and Rheumatology , 74(12), pp. 1959-1970. (doi:10.1002/art.42280 ) (PMID:35829656)

  7. 87
    دورية أكاديمية

    وصف الملف: text

    العلاقة: https://eprints.gla.ac.uk/268428/1/268428.pdfTest; Merola, J. F., McInnes, I. B. , Deodhar, A. A., Dey, A. K., Adamstein, N. H., Quebe-Fehling, E., Aassi, M., Peine, M. and Mehta, N. N. (2022) Effect of secukinumab on traditional cardiovascular risk factors and inflammatory biomarkers: post hoc analyses of pooled data across three indications. Rheumatology and Therapy , 9(3), pp. 935-955. (doi:10.1007/s40744-022-00434-z ) (PMID:35305260) (PMCID:PMC9127026)

  8. 88
    دورية أكاديمية

    مصطلحات موضوعية: Body surface area, Humans, Psoriasis, Quality of life, TYK2

    وصف الملف: application/pdf

    العلاقة: Dermatology and Therapy; Vol. 12 (january 2022), p. 495-510; https://ddd.uab.cat/record/256010Test; urn:10.1007/s13555-021-00649-y; urn:oai:ddd.uab.cat:256010; urn:pmcid:PMC8850503; urn:pmc-uid:8850503; urn:pmid:35025062; urn:oai:pubmedcentral.nih.gov:8850503; urn:articleid:21909172v12p495; urn:oai:egreta.uab.cat:publications/bda75f31-cc7a-46b0-9f4e-52596e33af93

  9. 89
    دورية أكاديمية

    المصدر: Kohn , A H , Alavi , A , Armstrong , A W , Babalola , F , Garg , A , Gottlieb , A B , Grilli , L , Jemec , G B E , Latella , J , Marcus , K , Merola , J F , Ortega-Loayza , A G , Siegel , D M , Strand , V , Tan , J K L & Perez-Chada , L M 2022 , ' International Dermatology Outcome Measures (IDEOM) : Report from the 2020 Annual Meeting ' , Dermatology , vol. 238 , pp. 430–437 . ....

    وصف الملف: application/pdf

  10. 90
    دورية أكاديمية